Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
Demo Company

High Slew Rate 1.5 T MRI Designed for Advanced MR Applications

By Medimaging International staff writers
Posted on 04 Jan 2011
Certain magnetic resonance imaging (MRI) exams such as advanced cardiac and neuroimaging require a system with enhanced gradients for better image quality and quicker exams. For these applications, a new 1.5 Tesla (T) MR system has been developed with high slew rate gradients and new user interface, M-Power.

Toshiba Medical Systems (Tokyo, Japan) presented the new Vantage Titan HSR at the 2010 Radiological Society of North America (RSNA) annual meeting, held in Chicago, IL, USA, November 28-December 3, 2010.

The high slew rate (HSR) gradients (gradient strength 30 [mT/m] | slew rate 203 [mT/m/ms]) of the Titan HSR improve the capability for advanced cardiac and neurological applications as well as MR angiography (MRA) body, breast, and abdominal imaging. The new gradients improve temporal and spatial resolution and the ability for clinicians to make accurate diagnoses. The M-Power interface has many new efficiency tools as well as sophisticated postprocessing software available on the main console, enhancing department workflow. The system also features an open bore that is 18% larger than other 1.5 T systems on the market and features a large 71-cm patient aperture, excellent homogeneity, and an extremely high clinical field-of-view (FOV) of 55 cm x 55 cm x 50 cm, providing a very high level of patient care and diagnostic capability in MR imaging.

The Vantage Titan HSR is an enhancement to the Vantage Titan and therefore includes numerous patient-friendly features. The Vantage Titan HSR's patient-focused features significantly improve patient comfort and increase the range of patients who can be imaged with MR. The open bore provides a greater feeling of openness for the patient, and Toshiba's patented Pianissimo technology dramatically reduces acoustic noise, the most significant cause of patient discomfort during an MR exam. The Vantage Titan HSR also utilizes Toshiba's Atlas SPEEDER integrated coil technology to reduce exam time and improve the overall exam experience for patients. Because the coils are integrated into the table, patients do not need to be continually repositioned, which saves time and improves patient comfort. Moreover, many procedures can be performed feet first with a patient's head comfortably lying outside of the bore, considerably reducing claustrophobia.

The Vantage Titan HSR MR system also takes advantage of Toshiba's proprietary, contrast-free MRA techniques: fresh blood imaging (FBI), contrast-free improved angiography (CIA), time-spatial labeling inversion pulse (Time-SLIP) and time space angiography (TSA). Contrast-free imaging is particularly important because gadolinium, the most common contrast agent used for magnetic resonance imaging (MRI) and MRA exams, has been directly linked to a sometimes-fatal disease that occurs in patients with renal insufficiency, called nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD).

"Combining high slew rate gradients with the Vantage Titan's patient-focused features creates the premium 1.5 T MR system on the market,” said Stuart Clarkson, director, MR business unit, Toshiba. "Advanced MR applications are allowing patients to undergo safer imaging with no radiation, all while providing highly accurate information for diagnosis.”

Related Links:

Toshiba Medical Systems






Channels

Ultrasound

view channel

New Guideline Released for the Diagnosis of Heart Detects Using Echocardiograms

New guidelines for the assessment of Atrial Septal Defects (ASD) and Patent Foramen Ovale (PFO) using echocardiography have been released by the American Society of Echocardiography (ASE) and the Society for Cardiac Angiography and Interventions (SCAI). The paper is being published in the August 2015, issue of the Journal... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel

OCT-Guided Stent Implantation, IVUS, and Angiography-Guided PCI Compared

A medical device vendor has announced the launch of a clinical study to compare intravascular assessments and Percutaneous Coronary Intervention (PCI) during stent implantation, using guidance by Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS) or only angiography. The ILUMIEN III multicenter randomized... Read more

Imaging IT

view channel
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).

Oncology Software Update Compliant with New BTS Guidelines

A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.... Read more

Industry News

view channel

International Healthcare Solutions Provider and US Healthcare Consultancy Agree Strategic Partnership

A leading US healthcare consultancy and an international Healthcare Information Technology (HIT) solutions provider have forged a partnership to find joint opportunities in the medical imaging market. HIT systems are intended to help clinicians make clinical decisions, and can be designed so that they can predict which... Read more
 

Events

11 Sep 2015 - 12 Sep 2015
19 Sep 2015 - 24 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.